1 Study Coverage 1.1 Cyclophosphamide Product Introduction 1.2 Market by Type 1.2.1 Global Cyclophosphamide Market Size Growth Rate by Type 1.2.2 High-Dose 1.2.3 Low-Dose 1.3 Market by Application 1.3.1 Global Cyclophosphamide Market Size Growth Rate by Application 1.3.2 Cancer 1.3.3 Autoimmune Diseases 1.3.4 AL Amyloidosis 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cyclophosphamide Market Size, Estimates and Forecasts 2.1.1 Global Cyclophosphamide Revenue 2016-2027 2.1.2 Global Cyclophosphamide Sales 2016-2027 2.2 Global Cyclophosphamide, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cyclophosphamide Historical Market Size by Region (2016-2021) 2.3.1 Global Cyclophosphamide Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cyclophosphamide Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cyclophosphamide Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cyclophosphamide Sales Forecast by Region (2022-2027) 2.4.2 Global Cyclophosphamide Revenue Forecast by Region (2022-2027) 3 Global Cyclophosphamide Competitor Landscape by Players 3.1 Global Top Cyclophosphamide Manufacturers by Sales 3.1.1 Global Cyclophosphamide Sales by Manufacturer (2016-2021) 3.1.2 Global Cyclophosphamide Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cyclophosphamide Manufacturers by Revenue 3.2.1 Key Cyclophosphamide Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cyclophosphamide Revenue by Manufacturers (2016-2021) 3.2.3 Global Cyclophosphamide Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cyclophosphamide Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cyclophosphamide Revenue in 2020 3.2.6 Global Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cyclophosphamide Price by Manufacturers 3.4 Global Cyclophosphamide Manufacturing Base Distribution, Product Types 3.4.1 Cyclophosphamide Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cyclophosphamide Product Type 3.4.3 Date of International Manufacturers Enter into Cyclophosphamide Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cyclophosphamide Market Size by Type (2016-2021) 4.1.1 Global Cyclophosphamide Sales by Type (2016-2021) 4.1.2 Global Cyclophosphamide Revenue by Type (2016-2021) 4.1.3 Cyclophosphamide Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cyclophosphamide Market Size Forecast by Type (2022-2027) 4.2.1 Global Cyclophosphamide Sales Forecast by Type (2022-2027) 4.2.2 Global Cyclophosphamide Revenue Forecast by Type (2022-2027) 4.2.3 Cyclophosphamide Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cyclophosphamide Market Size by Application (2016-2021) 5.1.1 Global Cyclophosphamide Sales by Application (2016-2021) 5.1.2 Global Cyclophosphamide Revenue by Application (2016-2021) 5.1.3 Cyclophosphamide Price by Application (2016-2021) 5.2 Cyclophosphamide Market Size Forecast by Application (2022-2027) 5.2.1 Global Cyclophosphamide Sales Forecast by Application (2022-2027) 5.2.2 Global Cyclophosphamide Revenue Forecast by Application (2022-2027) 5.2.3 Global Cyclophosphamide Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Cyclophosphamide Market Size YoY Growth 2016-2027 6.1.1 United States Cyclophosphamide Sales YoY Growth 2016-2027 6.1.2 United States Cyclophosphamide Revenue YoY Growth 2016-2027 6.1.3 United States Cyclophosphamide Market Share in Global Market 2016-2027 6.2 United States Cyclophosphamide Market Size by Players (International and Local Players) 6.2.1 United States Top Cyclophosphamide Players by Sales (2016-2021) 6.2.2 United States Top Cyclophosphamide Players by Revenue (2016-2021) 6.3 United States Cyclophosphamide Historic Market Review by Type (2016-2021) 6.3.1 United States Cyclophosphamide Sales Market Share by Type (2016-2021) 6.3.2 United States Cyclophosphamide Revenue Market Share by Type (2016-2021) 6.3.3 United States Cyclophosphamide Price by Type (2016-2021) 6.4 United States Cyclophosphamide Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Cyclophosphamide Sales Forecast by Type (2022-2027) 6.4.2 United States Cyclophosphamide Revenue Forecast by Type (2022-2027) 6.4.3 United States Cyclophosphamide Price Forecast by Type (2022-2027) 6.5 United States Cyclophosphamide Historic Market Review by Application (2016-2021) 6.5.1 United States Cyclophosphamide Sales Market Share by Application (2016-2021) 6.5.2 United States Cyclophosphamide Revenue Market Share by Application (2016-2021) 6.5.3 United States Cyclophosphamide Price by Application (2016-2021) 6.6 United States Cyclophosphamide Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Cyclophosphamide Sales Forecast by Application (2022-2027) 6.6.2 United States Cyclophosphamide Revenue Forecast by Application (2022-2027) 6.6.3 United States Cyclophosphamide Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cyclophosphamide Market Size YoY Growth 2016-2027 7.2 North America Cyclophosphamide Market Facts & Figures by Country 7.2.1 North America Cyclophosphamide Sales by Country (2016-2021) 7.2.2 North America Cyclophosphamide Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cyclophosphamide Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cyclophosphamide Market Facts & Figures by Region 8.2.1 Asia Pacific Cyclophosphamide Sales by Region (2016-2021) 8.2.2 Asia Pacific Cyclophosphamide Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cyclophosphamide Market Size YoY Growth 2016-2027 9.2 Europe Cyclophosphamide Market Facts & Figures by Country 9.2.1 Europe Cyclophosphamide Sales by Country (2016-2021) 9.2.2 Europe Cyclophosphamide Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cyclophosphamide Market Size YoY Growth 2016-2027 10.2 Latin America Cyclophosphamide Market Facts & Figures by Country 10.2.1 Latin America Cyclophosphamide Sales by Country (2016-2021) 10.2.2 Latin America Cyclophosphamide Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cyclophosphamide Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cyclophosphamide Market Facts & Figures by Country 11.2.1 Middle East and Africa Cyclophosphamide Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cyclophosphamide Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Baxter 12.1.1 Baxter Corporation Information 12.1.2 Baxter Description and Business Overview 12.1.3 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Baxter Cyclophosphamide Products Offered 12.1.5 Baxter Recent Development 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Description and Business Overview 12.2.3 Novartis Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis Cyclophosphamide Products Offered 12.2.5 Novartis Recent Development 12.3 Hikma Pharmaceuticals 12.3.1 Hikma Pharmaceuticals Corporation Information 12.3.2 Hikma Pharmaceuticals Description and Business Overview 12.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Hikma Pharmaceuticals Cyclophosphamide Products Offered 12.3.5 Hikma Pharmaceuticals Recent Development 12.4 Amneal Pharmaceuticals LLC 12.4.1 Amneal Pharmaceuticals LLC Corporation Information 12.4.2 Amneal Pharmaceuticals LLC Description and Business Overview 12.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Products Offered 12.4.5 Amneal Pharmaceuticals LLC Recent Development 12.5 Jiangsu Hengrui Medicine 12.5.1 Jiangsu Hengrui Medicine Corporation Information 12.5.2 Jiangsu Hengrui Medicine Description and Business Overview 12.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Products Offered 12.5.5 Jiangsu Hengrui Medicine Recent Development 12.6 NorthStar Rx LLC 12.6.1 NorthStar Rx LLC Corporation Information 12.6.2 NorthStar Rx LLC Description and Business Overview 12.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.6.4 NorthStar Rx LLC Cyclophosphamide Products Offered 12.6.5 NorthStar Rx LLC Recent Development 12.7 GLS Pharma 12.7.1 GLS Pharma Corporation Information 12.7.2 GLS Pharma Description and Business Overview 12.7.3 GLS Pharma Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.7.4 GLS Pharma Cyclophosphamide Products Offered 12.7.5 GLS Pharma Recent Development 12.8 CSC Pharmaceuticals International 12.8.1 CSC Pharmaceuticals International Corporation Information 12.8.2 CSC Pharmaceuticals International Description and Business Overview 12.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CSC Pharmaceuticals International Cyclophosphamide Products Offered 12.8.5 CSC Pharmaceuticals International Recent Development 12.11 Baxter 12.11.1 Baxter Corporation Information 12.11.2 Baxter Description and Business Overview 12.11.3 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Baxter Cyclophosphamide Products Offered 12.11.5 Baxter Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cyclophosphamide Industry Trends 13.2 Cyclophosphamide Market Drivers 13.3 Cyclophosphamide Market Challenges 13.4 Cyclophosphamide Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cyclophosphamide Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Cyclophosphamide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of High-Dose Table 3. Major Manufacturers of Low-Dose Table 4. Global Cyclophosphamide Market Size Growth Rate by Application (2021-2027) & (Person) Table 5. Global Cyclophosphamide Market Size by Region (Person) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Cyclophosphamide Sales by Regions (2016-2021) & (Person) Table 7. Global Cyclophosphamide Sales Market Share by Regions (2016-2021) Table 8. Global Cyclophosphamide Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Cyclophosphamide Sales Forecast by Region (2022-2027) & (Person) Table 10. Global Cyclophosphamide Sales Market Share Forecast by Region (2022-2027) Table 11. Global Cyclophosphamide Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Cyclophosphamide Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Cyclophosphamide Sales by Manufacturers (2016-2021) (Person) Table 14. Global Cyclophosphamide Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Cyclophosphamide Manufacturers by Revenue (US$ Million) in 2020 Table 16. Cyclophosphamide Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Cyclophosphamide Revenue Share by Manufacturers (2016-2021) Table 18. Global Cyclophosphamide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Cyclophosphamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclophosphamide as of 2020) Table 20. Key Manufacturers Cyclophosphamide Price (2016-2021) (Average Cost/Person) Table 21. Cyclophosphamide Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Cyclophosphamide Product Type Table 23. Date of International Manufacturers Enter into Cyclophosphamide Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Cyclophosphamide Sales by Type (2016-2021) (Person) Table 26. Global Cyclophosphamide Sales Share by Type (2016-2021) Table 27. Global Cyclophosphamide Revenue by Type (2016-2021) (US$ Million) Table 28. Global Cyclophosphamide Revenue Share by Type (2016-2021) Table 29. Cyclophosphamide Average Selling Price (ASP) by Type (2016-2021) & (Average Cost/Person) Table 30. Global Cyclophosphamide Sales Forecast by Type (2022-2027) & (Person) Table 31. Global Cyclophosphamide Sales Market Share Forecast by Type (2022-2027) Table 32. Global Cyclophosphamide Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Cyclophosphamide Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Cyclophosphamide Average Selling Price (ASP) Forecast by Type (2022-2027) & (Average Cost/Person) Table 35. Global Cyclophosphamide Sales by Application (2016-2021) (Person) Table 36. Global Cyclophosphamide Sales Share by Application (2016-2021) Table 37. Global Cyclophosphamide Revenue by Application (2016-2021) (US$ Million) Table 38. Global Cyclophosphamide Revenue Share by Application (2016-2021) Table 39. Cyclophosphamide Average Selling Price (ASP) by Application (2016-2021) & (Average Cost/Person) Table 40. Global Cyclophosphamide Sales Forecast by Application (2022-2027) & (Person) Table 41. Global Cyclophosphamide Sales Market Share Forecast by Application (2022-2027) Table 42. Global Cyclophosphamide Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Cyclophosphamide Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Cyclophosphamide Average Selling Price (ASP) Forecast by Application (2022-2027) & (Average Cost/Person) Table 45. United States Cyclophosphamide Sales (Person) of Key Companies (2016-2021) Table 46. United States Cyclophosphamide Sales Share by Company (2016-2021) Table 47. United States Cyclophosphamide Revenue (US$ Million) by Company (2016-2021) Table 48. United States Cyclophosphamide Revenue Share by Company (2016-2021) Table 49. United States Cyclophosphamide Sales (Person) by Type (2016-2021) Table 50. United States Cyclophosphamide Sales Share by Type (2016-2021) Table 51. United States Cyclophosphamide Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. United States Cyclophosphamide Price (Average Cost/Person) by Type (2016-2021) Table 53. United States Cyclophosphamide Sales (Person) by Type (2022-2027) Table 54. United States Cyclophosphamide Sales Share by Type (2022-2027) Table 55. United States Cyclophosphamide Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. United States Cyclophosphamide Revenue Share by Type (2022-2027) Table 57. United States Cyclophosphamide Price (Average Cost/Person) by Type (2022-2027) Table 58. United States Cyclophosphamide Sales (Person) by Application (2016-2021) Table 59. United States Cyclophosphamide Sales Share by Application (2016-2021) Table 60. United States Cyclophosphamide Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. United States Cyclophosphamide Price (Average Cost/Person) by Application (2016-2021) Table 62. United States Cyclophosphamide Sales (Person) by Application (2022-2027) Table 63. United States Cyclophosphamide Sales Share by Application (2022-2027) Table 64. United States Cyclophosphamide Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. United States Cyclophosphamide Revenue Share by Application (2022-2027) Table 66. United States Cyclophosphamide Price (Average Cost/Person) by Application (2022-2027) Table 67. North America Cyclophosphamide Sales by Country (2016-2021) & (Person) Table 68. North America Cyclophosphamide Sales Market Share by Country (2016-2021) Table 69. North America Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Cyclophosphamide Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Cyclophosphamide Sales by Region (2016-2021) & (Person) Table 72. Asia Pacific Cyclophosphamide Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Cyclophosphamide Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Cyclophosphamide Revenue Market Share by Region (2016-2021) Table 75. Europe Cyclophosphamide Sales by Country (2016-2021) & (Person) Table 76. Europe Cyclophosphamide Sales Market Share by Country (2016-2021) Table 77. Europe Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Cyclophosphamide Revenue Market Share by Country (2016-2021) Table 79. Latin America Cyclophosphamide Sales by Country (2016-2021) & (Person) Table 80. Latin America Cyclophosphamide Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Cyclophosphamide Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Cyclophosphamide Sales by Country (2016-2021) & (Person) Table 84. Middle East and Africa Cyclophosphamide Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Cyclophosphamide Revenue Market Share by Country (2016-2021) Table 87. Baxter Corporation Information Table 88. Baxter Description and Business Overview Table 89. Baxter Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 90. Baxter Cyclophosphamide Product Table 91. Baxter Recent Development Table 92. Novartis Corporation Information Table 93. Novartis Description and Business Overview Table 94. Novartis Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 95. Novartis Product Table 96. Novartis Recent Development Table 97. Hikma Pharmaceuticals Corporation Information Table 98. Hikma Pharmaceuticals Description and Business Overview Table 99. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 100. Hikma Pharmaceuticals Product Table 101. Hikma Pharmaceuticals Recent Development Table 102. Amneal Pharmaceuticals LLC Corporation Information Table 103. Amneal Pharmaceuticals LLC Description and Business Overview Table 104. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 105. Amneal Pharmaceuticals LLC Product Table 106. Amneal Pharmaceuticals LLC Recent Development Table 107. Jiangsu Hengrui Medicine Corporation Information Table 108. Jiangsu Hengrui Medicine Description and Business Overview Table 109. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 110. Jiangsu Hengrui Medicine Product Table 111. Jiangsu Hengrui Medicine Recent Development Table 112. NorthStar Rx LLC Corporation Information Table 113. NorthStar Rx LLC Description and Business Overview Table 114. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 115. NorthStar Rx LLC Product Table 116. NorthStar Rx LLC Recent Development Table 117. GLS Pharma Corporation Information Table 118. GLS Pharma Description and Business Overview Table 119. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 120. GLS Pharma Product Table 121. GLS Pharma Recent Development Table 122. CSC Pharmaceuticals International Corporation Information Table 123. CSC Pharmaceuticals International Description and Business Overview Table 124. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$ Million), Price (Average Cost/Person) and Gross Margin (2016-2021) Table 125. CSC Pharmaceuticals International Product Table 126. CSC Pharmaceuticals International Recent Development Table 127. Cyclophosphamide Market Trends Table 128. Cyclophosphamide Market Drivers Table 129. Cyclophosphamide Market Challenges Table 130. Cyclophosphamide Market Restraints Table 131. Cyclophosphamide Customers List Table 132. Cyclophosphamide Distributors List Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Cyclophosphamide Product Picture Figure 2. Global Cyclophosphamide Sales Market Share by Type in 2020 & 2027 Figure 3. High-Dose Product Picture Figure 4. Low-Dose Product Picture Figure 5. Global Cyclophosphamide Sales Market Share by Application in 2020 & 2027 Figure 6. Cancer Figure 7. Autoimmune Diseases Figure 8. AL Amyloidosis Figure 9. Others Figure 10. Cyclophosphamide Report Years Considered Figure 11. Global Cyclophosphamide Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Cyclophosphamide Market Size 2016-2027 (US$ Million) Figure 13. Global Cyclophosphamide Sales 2016-2027 (Person) Figure 14. Global Cyclophosphamide Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Cyclophosphamide Sales Market Share by Region (2016-2021) Figure 16. Global Cyclophosphamide Sales Market Share by Region in 2020 Figure 17. Global Cyclophosphamide Revenue Market Share by Region (2016-2021) Figure 18. Global Cyclophosphamide Revenue Market Share by Region in 2020 Figure 19. Global Cyclophosphamide Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Cyclophosphamide Revenue in 2020 Figure 21. Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Cyclophosphamide Sales Market Share by Type (2016-2021) Figure 23. Global Cyclophosphamide Sales Market Share by Type in 2020 Figure 24. Global Cyclophosphamide Revenue Market Share by Type (2016-2021) Figure 25. Global Cyclophosphamide Revenue Market Share by Type in 2020 Figure 26. Global Cyclophosphamide Sales Market Share by Application (2016-2021) Figure 27. Global Cyclophosphamide Sales Market Share by Application in 2020 Figure 28. Global Cyclophosphamide Revenue Market Share by Application (2016-2021) Figure 29. Global Cyclophosphamide Revenue Market Share by Application in 2020 Figure 30. United States Cyclophosphamide Sales Growth Rate 2016-2027 (Person) Figure 31. United States Cyclophosphamide Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. United States Cyclophosphamide Market Share in Global Market 2016-2027 Figure 33. United States 5 and 10 Largest Cyclophosphamide Players Market Share by Revenue in Cyclophosphamide in 2020 Figure 34. United States Cyclophosphamide Revenue Share by Type (2016-2021) Figure 35. United States Cyclophosphamide Revenue Growth Rate by Type in 2016 & 2020 Figure 36. United States Cyclophosphamide Revenue Share by Application (2016-2021) Figure 37. United States Cyclophosphamide Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Cyclophosphamide Sales Growth Rate 2016-2021 (Person) Figure 39. North America Cyclophosphamide Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Cyclophosphamide Sales Market Share by Country in 2020 Figure 41. North America Cyclophosphamide Revenue Market Share by Country in 2020 Figure 42. U.S. Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 43. U.S. Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 45. Canada Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Cyclophosphamide Sales Growth Rate 2016-2021 (Person) Figure 47. Europe Cyclophosphamide Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Cyclophosphamide Sales Market Share by Country in 2020 Figure 49. Europe Cyclophosphamide Revenue Market Share by Country in 2020 Figure 50. Germany Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 51. Germany Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 53. France Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 55. U.K. Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 57. Italy Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 59. Russia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Cyclophosphamide Sales Growth Rate 2016-2021 (Person) Figure 61. Asia Pacific Cyclophosphamide Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Cyclophosphamide Sales Market Share by Region in 2020 Figure 63. Asia Pacific Cyclophosphamide Revenue Market Share by Region in 2020 Figure 64. China Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 65. China Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 67. Japan Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 69. South Korea Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 71. India Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 73. Australia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 75. Taiwan Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 77. Indonesia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 79. Thailand Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 81. Malaysia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 83. Philippines Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 85. Vietnam Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Cyclophosphamide Sales Growth Rate 2016-2021 (Person) Figure 87. Latin America Cyclophosphamide Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Cyclophosphamide Sales Market Share by Country in 2020 Figure 89. Latin America Cyclophosphamide Revenue Market Share by Country in 2020 Figure 90. Mexico Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 91. Mexico Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 93. Brazil Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 95. Argentina Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Cyclophosphamide Sales Growth Rate 2016-2021 (Person) Figure 97. Middle East and Africa Cyclophosphamide Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Cyclophosphamide Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Cyclophosphamide Revenue Market Share by Country in 2020 Figure 100. Turkey Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 101. Turkey Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 103. Saudi Arabia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Cyclophosphamide Sales Growth Rate (2016-2021) (Person) Figure 105. UAE Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Cyclophosphamide Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Baxter Novartis Hikma Pharmaceuticals Amneal Pharmaceuticals LLC Jiangsu Hengrui Medicine NorthStar Rx LLC GLS Pharma CSC Pharmaceuticals International